SPIOLTO RESPIMAT Inhalation Solution
Olodaterol HCl, Tiotropium bromide monohydrate
2.5 mcg + 2.5 mcg
Boehringer Ingelheim Pharma GmbH & Co. KG
| Pack size | 1 Cartridge (4 ml) |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 178.70 AED |
Available as:
Indications
SPIOLTO RESPIMAT Inhalation Solution is used for:
OLODATEROL
Olodaterol is indicated for use in chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It is not indicated for the treatment of acute exacerbations of COPD or for the treatment of asthma.
TIOTROPIUM
Used in the management of chronic obstructive pulmonary disease (COPD).
Olodaterol is indicated for use in chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It is not indicated for the treatment of acute exacerbations of COPD or for the treatment of asthma.
TIOTROPIUM
Used in the management of chronic obstructive pulmonary disease (COPD).
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Olodaterol HCl, Tiotropium bromide monohydrate :
Mechanism of Action
OLODATEROL
Olodaterol is a long-acting beta2-adrenergic agonist (LABA) that exerts its pharmacological effect by binding and activating beta2-adrenergic receptors located primarily in the lungs. Beta2-adrenergic receptors are membrane-bound receptors that are normally activated by endogenous epinephrine whose signalling, via a downstream L-type calcium channel interaction, mediates smooth muscle relaxation and bronchodilation. Activation of the receptor stimulates an associated G protein which then activates adenylate cyclase, catalyzing the formation of cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA). Elevation of these two molecules induces bronchodilation by relaxation of airway smooth muscles.
TIOTROPIUM
Tiotropium is a muscarinic receptor antagonist, often referred to as an antimuscarinic or anticholinergic agent. Although it does not display selectivity for specific muscarinic receptors, on topical application it acts mainly on M3 muscarinic receptors located in the airways to produce smooth muscle relaxation, thus producing a bronchodilatory effect.
Olodaterol is a long-acting beta2-adrenergic agonist (LABA) that exerts its pharmacological effect by binding and activating beta2-adrenergic receptors located primarily in the lungs. Beta2-adrenergic receptors are membrane-bound receptors that are normally activated by endogenous epinephrine whose signalling, via a downstream L-type calcium channel interaction, mediates smooth muscle relaxation and bronchodilation. Activation of the receptor stimulates an associated G protein which then activates adenylate cyclase, catalyzing the formation of cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA). Elevation of these two molecules induces bronchodilation by relaxation of airway smooth muscles.
TIOTROPIUM
Tiotropium is a muscarinic receptor antagonist, often referred to as an antimuscarinic or anticholinergic agent. Although it does not display selectivity for specific muscarinic receptors, on topical application it acts mainly on M3 muscarinic receptors located in the airways to produce smooth muscle relaxation, thus producing a bronchodilatory effect.
Note
SPIOLTO RESPIMAT 2.5 mcg + 2.5 mcg Inhalation Solution manufactured by Boehringer Ingelheim Pharma GmbH & Co. KG. Its generic name is Olodaterol HCl, Tiotropium bromide monohydrate. SPIOLTO RESPIMAT is availble in Saudi Arabia.
Farmaco SA drug index information on SPIOLTO RESPIMAT Inhalation Solution is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.